Protara, hoping to ultimately transition to a commercial stage company, snagged a chief commercial officer in Bill Conkling, ...

Avenzo Therapeutics has commenced the open-label Phase I/II trial of its CDK4 selective inhibitor, AVZO-023, for breast ...

Gilead Sciences Inc. closed 7.92% below its 52-week high of $119.96, which the company achieved on March 10th.

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

Jefferies analyst Michael Yee reaffirmed a Buy rating on Gilead Sciences Inc. (NASDAQ:GILD), maintaining his price target at ...

Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” first quarter 2025 ...

The ASCENT-03 trial is a phase 3 study assessing the efficacy and safety of sacituzumab govitecan compared with physician’s choice of treatment in patients with previously untreated, locally advanced, ...

A Powerful and Emotional Final Chapter: If you thought The Handmaid’s Tale couldn’t dig any deeper into your soul, Season 6 is here to prove you wrong in the best way possible.

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

The funeral for Morrow County Sheriff’s Deputy Daniel “Weston” Sherrer will take place at 11 a.m. today at Northmor High ...

A private ceremony at Marion Cemetery is concluding a week’s worth of remembrance for a Morrow County deputy who was shot and ...

We’re proud to share that “The Adventure Jar,” a children’s book supporting families impacted by metastatic breast cancer (MBC), has received two 2025 Bronze Anvil Awards from the Public Relations ...